Skip to main content

Academic Career and Research Areas

Mohammadali Khan Mirzaei's research integrates experimental and computational approaches to gain a deep understanding of complex phage-host interactions with the aim of developing next-generation therapeutics to treat multi-drug resistant infections and engineer the human microbiome. To achieve this, he develops and combines a diverse array of methodologies, including single-cell techniques, -omics approaches, metabolic labeling, and model systems.

Professional Background

Since 05/2022

Vice head of the research unit/ Team leader at the Institute of Virology, Helmholtz Zentrum München and Technical University of Munich, Germany

06/2019 - 05/2022

Senior postdoctoral researcher at the Institute of Virology, Helmholtz Zentrum München and Technical University of Munich, Germany

Research topic: Novel phage-based therapeutics for treating multi-drug resistant infections and engineering the human microbiome

05/2016 - 04/2019

Postdoctoral researcher at the Department of Microbiology and Imunology, McGill University, Montreal, Canada

Research topic: Phage-bacteria interactions in the human gut and their role in health and disease

12/2011 - 03/2016

Ph.D. in Molecular Genetics at the Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden

Thesis: The efficacy of bacterial viruses against multi-resistant Escherichia coli: from isolation to Pharmacology

09/2009 - 10/2011

M.Sc. in Molecular life sciences at the Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden

Thesis: Isolation and characterization of phages against multi-resistant Escherichia coli